Dirk Scharr

The human <i>GRAF</i> gene is fused to <i>MLL</i> in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q

Arndt Borkhardt, Stig E. Bojesen, Oskar A. Haas et al. · Proceedings of the National Academy of Sciences · 2000 · 124 citations

Life Sciences, Genetics, Molecular Genetics +17

Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis

Ulrike Fasol, Annette Frost, Martin Büchert et al. · Annals of Oncology · 2011 · 104 citations · Full text

Medicine, Oncology, Pharmacokinetics +16

First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors

K. Mross, Heike Richly, Richard Fischer et al. · PLoS ONE · 2013 · 52 citations · Full text

Medicine, Oncology, Pharmacology +8

A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors

K. Mross, Heike Richly, Annette Frost et al. · Cancer Chemotherapy and Pharmacology · 2016 · 19 citations · Full text

Medicine, Oncology, Pharmacology +15

Abstract A212: First in human phase I study of PRS-050 (Angiocal), a VEGF-A targeting anticalin, in patients with advanced solid tumors: Results of a dose escalation study.

K. Mross, R. Fischer, Heike Richly et al. · Molecular Cancer Therapeutics · 2011 · 12 citations

Medicine, Oncology, Pharmacology +17